MX2013004417A - Peptidos wdhd1 y vacunas que los incluyen. - Google Patents
Peptidos wdhd1 y vacunas que los incluyen.Info
- Publication number
- MX2013004417A MX2013004417A MX2013004417A MX2013004417A MX2013004417A MX 2013004417 A MX2013004417 A MX 2013004417A MX 2013004417 A MX2013004417 A MX 2013004417A MX 2013004417 A MX2013004417 A MX 2013004417A MX 2013004417 A MX2013004417 A MX 2013004417A
- Authority
- MX
- Mexico
- Prior art keywords
- peptides
- same
- vaccines including
- peptide
- wdhd1
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 2
- 238000007792 addition Methods 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940023041 peptide vaccine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40551710P | 2010-10-21 | 2010-10-21 | |
| PCT/JP2011/005866 WO2012053206A1 (en) | 2010-10-21 | 2011-10-20 | Wdhd1 peptides and vaccines including the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013004417A true MX2013004417A (es) | 2013-05-22 |
Family
ID=45974936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013004417A MX2013004417A (es) | 2010-10-21 | 2011-10-20 | Peptidos wdhd1 y vacunas que los incluyen. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9056890B2 (enExample) |
| EP (1) | EP2630238A4 (enExample) |
| JP (1) | JP2014504146A (enExample) |
| KR (1) | KR20130138804A (enExample) |
| CN (1) | CN103270156B (enExample) |
| AU (1) | AU2011319359A1 (enExample) |
| BR (1) | BR112013009526A2 (enExample) |
| CA (1) | CA2815102A1 (enExample) |
| IL (1) | IL225552A0 (enExample) |
| MX (1) | MX2013004417A (enExample) |
| RU (1) | RU2013123045A (enExample) |
| SG (1) | SG189222A1 (enExample) |
| TW (1) | TW201216982A (enExample) |
| WO (1) | WO2012053206A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013317194B2 (en) | 2012-09-11 | 2018-07-12 | Oncotherapy Science, Inc. | UBE2T peptides and vaccines containing the same |
| MX2019008878A (es) | 2017-01-25 | 2020-02-13 | Ose Immunotherapeutics | Metodo para fabricar una emulsion estable para suministro de peptidos. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004018667A1 (ja) * | 2002-08-26 | 2004-03-04 | Kirin Beer Kabushiki Kaisha | ペプチド及びこれを含む医薬 |
| JP2008540340A (ja) | 2005-04-28 | 2008-11-20 | マクギル ユニバーシティー | カドヘリン介在過程を調節する化合物及び方法 |
| EP2190985A4 (en) | 2007-08-24 | 2010-12-15 | Oncotherapy Science Inc | GENES RELATED TO CANCER, CDCA5, EPHA7, STK31 AND WDHD1 |
| US20100159513A1 (en) | 2008-12-20 | 2010-06-24 | E. I. Du Pont De Nemours And Compnay | Genes that increase peptide production |
-
2011
- 2011-10-19 TW TW100137833A patent/TW201216982A/zh unknown
- 2011-10-20 CN CN201180060624.7A patent/CN103270156B/zh not_active Expired - Fee Related
- 2011-10-20 US US13/880,442 patent/US9056890B2/en not_active Expired - Fee Related
- 2011-10-20 RU RU2013123045/10A patent/RU2013123045A/ru not_active Application Discontinuation
- 2011-10-20 BR BR112013009526A patent/BR112013009526A2/pt not_active IP Right Cessation
- 2011-10-20 KR KR1020137012792A patent/KR20130138804A/ko not_active Withdrawn
- 2011-10-20 SG SG2013024427A patent/SG189222A1/en unknown
- 2011-10-20 EP EP11834052.0A patent/EP2630238A4/en not_active Withdrawn
- 2011-10-20 WO PCT/JP2011/005866 patent/WO2012053206A1/en not_active Ceased
- 2011-10-20 MX MX2013004417A patent/MX2013004417A/es not_active Application Discontinuation
- 2011-10-20 JP JP2013518619A patent/JP2014504146A/ja not_active Withdrawn
- 2011-10-20 CA CA2815102A patent/CA2815102A1/en not_active Abandoned
- 2011-10-20 AU AU2011319359A patent/AU2011319359A1/en not_active Abandoned
-
2013
- 2013-04-04 IL IL225552A patent/IL225552A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013123045A (ru) | 2014-11-27 |
| WO2012053206A1 (en) | 2012-04-26 |
| BR112013009526A2 (pt) | 2017-05-02 |
| IL225552A0 (en) | 2013-06-27 |
| SG189222A1 (en) | 2013-06-28 |
| KR20130138804A (ko) | 2013-12-19 |
| AU2011319359A1 (en) | 2013-05-02 |
| US20130309259A1 (en) | 2013-11-21 |
| US9056890B2 (en) | 2015-06-16 |
| CN103270156B (zh) | 2015-09-02 |
| CN103270156A (zh) | 2013-08-28 |
| EP2630238A4 (en) | 2014-02-19 |
| TW201216982A (en) | 2012-05-01 |
| EP2630238A1 (en) | 2013-08-28 |
| JP2014504146A (ja) | 2014-02-20 |
| CA2815102A1 (en) | 2012-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019502194A1 (en) | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer | |
| NZ733168A (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| HK1244666A1 (zh) | 用於肺癌(包括非小细胞肺癌和其他癌)免疫治疗的新型肽和肽组合物 | |
| EP3412304A3 (en) | Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use | |
| MX2011007963A (es) | Peptidos neil3 y vacunas que incluyen los mismos. | |
| MX2018010565A (es) | Inmunoterapia novedosa contra varios tumores, tales como cancer de pulmon, que incluyen cancer de pulmon de celula no pequeña (nsclc). | |
| NZ609916A (en) | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof | |
| JP2014502961A5 (enExample) | ||
| PH12014500720A1 (en) | Topk peptides and vaccines including the same | |
| EP2528937A4 (en) | MODIFIED MELK-PEPTIDES AND VACCINES CONTAINING THEREOF | |
| EP3868778A3 (en) | Cdc45l peptides and vaccines including the same | |
| PH12013501105A1 (en) | Tomm34 peptides and vaccines including the same | |
| MX2011008917A (es) | Peptidos vangl1 y vacunas que incluyen los mismos. | |
| NZ592461A (en) | Rab6kifl/kif20a epitope peptide and vaccines containing the same | |
| MX2013004417A (es) | Peptidos wdhd1 y vacunas que los incluyen. | |
| EP2513136A4 (en) | PEPTIDES TMEM22 AND VACCINES COMPRISING THEM | |
| BR112013009276A2 (pt) | peptídeos de c18orf54 e vacinas incluindo os mesmos | |
| MY170949A (en) | A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine | |
| EP4047009A3 (en) | Wdrpuh epitope peptides and vaccines containing the same | |
| NZ746513A (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| TH158366A (th) | Topk เปปไทด์ และวัคซีนที่รวมถึงสิ่งเดียวกันนั้น | |
| MY198397A (en) | Novel Immunotherapy Against Several Tumors Including Gastrointestinal And Gastric Cancer | |
| HK1159526A1 (zh) | 包括肿瘤相关肽的组合物和用於治疗脑胶质瘤及其他肿瘤的疫苗 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |